Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.
about
Pancreatic Cancer GeneticsDevelopmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular OriginEpidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaSilencing Mist1 Gene Expression Is Essential for Recovery from Acute PancreatitisRegulation of Cellular Identity in CancerThe nuclear hormone receptor family member NR5A2 controls aspects of multipotent progenitor cell formation and acinar differentiation during pancreatic organogenesisThree new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21The secret origins and surprising fates of pancreas tumorsNuclear receptors and pathogenesis of pancreatic cancer.Limited evidence that cancer susceptibility regions are preferential targets for somatic mutationTranscriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cellsIntegrative analysis of haplotype-resolved epigenomes across human tissues.The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinomaLiver receptor homolog-1 (LRH-1): a potential therapeutic target for cancerGenome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese.BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis.Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.Beyond GWASs: illuminating the dark road from association to functionA new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm).PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance.Pathogenesis of pancreatic cancer: lessons from animal models.Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers.The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation.Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis.Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer.Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas.Inherited pancreatic cancer.Mnk1 is a novel acinar cell-specific kinase required for exocrine pancreatic secretion and response to pancreatitis in mice.Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case-control studies.Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment.Arid1a restrains Kras-dependent changes in acinar cell identity.
P2860
Q26765235-885D0AD5-D294-4FDA-A466-5E0CF5CE848AQ26774942-EF47F71A-8EBF-4E7A-8C30-2DC2FEACCF18Q26801418-E68D86FA-DEF9-45EF-BB2F-75A9DAA2CC9BQ27334054-377BE3BB-B862-431E-8735-6B62F9FD97B5Q28086849-87D8E831-6756-4288-924B-22D5D84646EFQ28511736-769E631F-DAD0-43B2-A45C-F53BC7843E05Q29248193-7EBE2E05-5E8F-436F-99D7-4E000EA3709BQ33827679-9D43488C-F535-4A6D-AFFB-B8907D7E630CQ34168476-63C06B0D-CEE1-4C3F-9C31-A9E185617161Q34494290-67EAE45C-31D9-4613-A333-5A1226917CE3Q34586212-FD97A7F5-4667-4C3A-86F7-64785E68744FQ35151728-6C30AA19-A06A-48DA-9316-600BB1D7720BQ35665495-B7A648BC-70A1-46B1-A546-8A695763785DQ35954277-9E6A12B8-3B4F-42CD-B2E5-0E2D17568EE8Q36213555-EC9A46E6-C49C-4D2D-A8D5-DFAE610B8E07Q36305832-A859E000-9938-48A6-86DE-A33E7F6172E4Q36506766-F120C084-5FCC-45F1-A60A-564225C4D975Q36700012-B2EBD6BD-F9A5-4EFF-8878-EBF89CD3EE10Q37298148-1BC6F20E-E593-4E90-8E27-2F95BCC3C212Q37545090-72EF2A3F-533B-40EC-AD59-DC382873685BQ37587988-3620F7FE-FE17-45F9-A0AE-42FA161E029DQ37589374-C43EDC64-1B6A-4FCF-9C22-7C1B131FA511Q38725295-B7B52A9F-FBB5-47C8-BB79-6D44C456624CQ38919135-9790A892-11FD-4E4E-BB8F-0143013F7944Q38922230-0A857804-7F63-451F-B86D-B86FE9F1C1F3Q39156056-7930ABF0-14E0-4DA3-A8BD-FC7C6A524CF0Q39384816-DEC6174E-DF65-4389-B91E-5CC1A52E1C60Q48234356-21580F2E-FB65-454A-8527-5AF8B8E482D5Q50001765-60CD834A-02C8-440B-AE72-B26682F02CCCQ50146622-5A6DFD4F-7C61-4831-8719-93CC900F8CE8Q54337011-B3DE3082-6701-4710-9AE8-B3E9EFD86E3DQ54975203-385DF991-2BD1-475F-8992-DBF725CB0BADQ55516479-64D4608F-2438-4702-86E6-1534301F7FE0Q55713410-B9CAA91E-5849-4B1B-B30E-989C1EFCDD2A
P2860
Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Nr5a2 heterozygosity sensitise ...... ven pancreatic tumourigenesis.
@en
Nr5a2 heterozygosity sensitise ...... ven pancreatic tumourigenesis.
@nl
type
label
Nr5a2 heterozygosity sensitise ...... ven pancreatic tumourigenesis.
@en
Nr5a2 heterozygosity sensitise ...... ven pancreatic tumourigenesis.
@nl
prefLabel
Nr5a2 heterozygosity sensitise ...... ven pancreatic tumourigenesis.
@en
Nr5a2 heterozygosity sensitise ...... ven pancreatic tumourigenesis.
@nl
P2093
P2860
P1433
P1476
Nr5a2 heterozygosity sensitise ...... iven pancreatic tumourigenesis
@en
P2093
Antonio Salas
Francisco X Real
Kristina Schoonjans
Marta Cañamero
Natalia del Pozo
P2860
P304
P356
10.1136/GUTJNL-2012-304381
P407
P577
2013-04-18T00:00:00Z